产品名称 | NebuSelect™ Recombinant Human LRP-5, mFc-tag |
---|---|
目录号 | NBL-242329 |
别名 | LRP-5; LRP-5; LRP-7; LR3; BMND1; BMND1OPTA1; EVR1; EVR4; HBM; LR3VBCH2; LRP5; LRP7; OPPG; OPS; OPTA1; VBCH2 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | O75197-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242329-100ug | 100ug | Inquire | Inquire | |
NBL-242329-1mg | 1mg | Inquire | Inquire | |
NBL-242329-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human LRP-5, mFc-tag
Catalog#:
NBL-242329
Description:
NebuSelect™ Recombinant Human LRP-5, mFc-tag(Cat#NBL-242329) is expressed in HEK293 with mFc (IgG1) tag at the C-Terminus.It contains Glu644-Gln1263.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 96 kDa. Due to glycosylation, the protein migrates to 100-115 kDa based on Bis-Tris PAGE result.
Target Name:
LRP-5; LRP-5; LRP-7; LR3; BMND1; BMND1OPTA1; EVR1; EVR4; HBM; LR3VBCH2; LRP5; LRP7; OPPG; OPS; OPTA1; VBCH2
Target Information:
A role for low-density lipoprotein-related receptor 5 (LRP5) in human bone was first established by the identification of genetic alterations that led to dramatic changes in bone mass. Shortly thereafter, mutations that altered the function of the sclerostin (SOST) gene were also associated with altered human bone mass. Subsequent studies of LRP5 and sclerostin have provided important insights into the mechanisms by which these proteins regulate skeletal homeostasis.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.